GC
MRK icon

Gould Capital’s Merck MRK Stock Holding History

Gould Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.76M Buy
29,265
+229
+0.8% +$26.8K 2.1% 11
2026
Q1 		$3.49M Sell
29,036
-2,631
-8% -$304K 2.11% 12
2025
Q4 		$3.33M Sell
31,667
-259
-0.8% -$24.3K 2.05% 14
2025
Q3 		$2.68M Buy
31,926
+1,006
+3% +$82.9K 1.66% 23
2025
Q2 		$2.45M Buy
30,920
+1,106
+4% +$87.9K 1.64% 23
2025
Q1 		$2.68M Buy
29,814
+5,229
+21% +$488K 1.87% 22
2024
Q4 		$2.45M Buy
24,585
+217
+0.9% +$22.4K 1.7% 24
2024
Q3 		$2.77M Sell
24,368
-52
-0.2% -$6.18K 1.82% 24
2024
Q2 		$3.02M Sell
24,420
-580
-2% -$74.7K 2.13% 20
2024
Q1 		$3.3M Buy
25,000
+132
+0.5% +$16.3K 2.32% 13
2023
Q4 		$2.71M Buy
24,868
+262
+1% +$27.2K 1.98% 20
2023
Q3 		$2.52M Sell
24,606
-46
-0.2% -$4.96K 2.04% 19
2023
Q2 		$2.84M Sell
24,652
-908
-4% -$103K 2.18% 16
2023
Q1 		$2.72M Sell
25,560
-9,868
-28% -$1.07M 2.1% 18
2022
Q4 		$3.93M Sell
35,428
-1,620
-4% -$166K 3.14% 6
2022
Q3 		$3.19M Sell
37,048
-257
-0.7% -$22.9K 2.76% 9
2022
Q2 		$3.4M Sell
37,305
-793
-2% -$70.3K 2.74% 9
2022
Q1 		$3.13M Buy
38,098
+936
+3% +$73.8K 2.25% 15
2021
Q4 		$2.85M Buy
+37,162
New +$2.96M 1.99% 19

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Gould Capital's MRK Position: Q2 2026 in Review

Gould Capital increased its Merck (MRK) stake by 0.79% in Q2 2026, buying an estimated $26.8K and bringing the position to 29,265 shares worth $3.76M. The position accounts for 2.1% of the portfolio, ranked #11.

Gould Capital first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.93M in Q4 2022. 3,837 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Gould Capital held 29,265 shares of Merck worth $3.76M as of Q2 2026.
  • Gould Capital bought 229 Merck shares in Q2 2026, an estimated $26.8K.
  • Merck made up 2.1% of Gould Capital's portfolio in Q2 2026, its #11 holding.
  • Gould Capital first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
  • Gould Capital's Merck position peaked at $3.93M in Q4 2022.
  • 3,837 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Gould Capital's 13F filing for Q2 2026, filed 7 Aug 2026.